Samidorphan

• CAT Number: I048013
• CAS Number: 852626-89-2
• Molecular Formula: C21H26N2O4
• Molecular Weight: 370.4
• Purity: 98%
• Synonyms: ALKS 33
• Target: μ-opioid receptor
• Target Protein: RYIDHLJADOKWFM-MAODMQOUSA-N
• Appearance: Solid
• IC50: Samidorphan binds to the μ-, κ-, and δ-opioid receptors (Ki = 0.052, 0.23, and 2.7 nM, respectively).
• IUPAC Name: (1R,9R,10S)-17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide
• InChI: InChI=1S/C21H26N2O4/c22-19(26)15-4-3-13-9-16-21(27)6-5-14(24)10-20(21,17(13)18(15)25)7-8-23(16)11-12-1-2-12/h3-4,12,16,25,27H,1-2,5-11H2,(H2,22,26)/t16-,20-,21-/m1/s1
• SMILES: C1CC1CN2CCC34CC(=O)CCC3(C2CC5=C4C(=C(C=C5)C(=O)N)O)O

Samidorphan (CAS 852626-89-2) is a potent opioid receptor antagonist that acts as a μ-opioid receptor antagonist and a partial κ-opioid receptor agonist. Developed for its potential application in treating various neuropsychiatric disorders, Samidorphan is being investigated, particularly in combination with other medications, to address conditions like schizophrenia and substance use disorders. By modulating the opioid system, Samidorphan aims to mitigate unwanted side effects associated with opioid agonists while offering therapeutic benefits.